
PerkinElmer PKI
Annual report 2025
added 02-24-2026
PerkinElmer Total Inventories 2011-2026 | PKI
Annual Total Inventories PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 379 M | 368 M | 428 M | 426 M | 515 M | - | 357 M | 338 M | 352 M | 288 M | - | 285 M | 261 M | 248 M | 207 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 515 M | 207 M | 342 M |
Quarterly Total Inventories PerkinElmer
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 380 M | 388 M | 381 M | 368 M | 405 M | 401 M | 414 M | 428 M | 436 M | 437 M | 429 M | 405 M | 378 M | 624 M | 646 M | 515 M | 645 M | 513 M | 530 M | - | 487 M | 478 M | 393 M | 357 M | 357 M | 357 M | 357 M | 338 M | 338 M | 338 M | 338 M | 352 M | 352 M | 352 M | 352 M | 259 M | 306 M | 300 M | 314 M | - | 313 M | 305 M | 291 M | 285 M | 285 M | 285 M | 285 M | 261 M | 261 M | 261 M | 261 M | 248 M | 248 M | 248 M | 248 M | 207 M | 229 M | 222 M | 225 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 646 M | 207 M | 358 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
830 M | $ 113.86 | -0.84 % | $ 34.6 B | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 17.54 | -1.6 % | $ 935 M | ||
|
Danaher Corporation
DHR
|
2.49 B | $ 189.99 | -1.09 % | $ 135 B | ||
|
DexCom
DXCM
|
629 M | $ 63.27 | 0.09 % | $ 24.7 B | ||
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 16.3 | -0.03 % | $ 175 M | ||
|
Co-Diagnostics
CODX
|
992 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 168.38 | 0.1 % | $ 8.35 B | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 24.8 | 0.26 % | $ 689 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
85.9 M | $ 90.77 | 1.23 % | $ 11.4 B | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 108.32 | -1.19 % | $ 8.93 B | ||
|
Illumina
ILMN
|
547 M | $ 126.53 | -0.95 % | $ 20.1 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.13 | -1.84 % | $ 4.89 M | ||
|
BioNano Genomics
BNGO
|
7.83 M | $ 1.15 | -0.43 % | $ 6.26 M | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 1.99 | 1.02 % | $ 8.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 271.64 | -1.06 % | $ 22.6 B | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 76.57 | 0.89 % | $ 5.17 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 4.64 | -0.64 % | $ 430 M | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
28.6 M | $ 7.94 | -1.0 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
191 M | $ 9.94 | 3.97 % | $ 2.16 B | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 197.89 | -0.58 % | $ 22 B | ||
|
Natera
NTRA
|
35.4 M | $ 207.28 | 1.18 % | $ 20.4 B | ||
|
ENDRA Life Sciences
NDRA
|
2.62 M | $ 4.8 | 1.27 % | $ 3.78 M | ||
|
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.45 | 1.76 % | $ 435 M | ||
|
Precipio
PRPO
|
935 K | $ 26.45 | 1.79 % | $ 42.5 M | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B |